Undoubtedly, after years of neglect, bronchiectasis has become a focus of respiratory research, largely thanks to the establishment of various bronchiectasis registries. Baseline data from registries ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Goldman Sachs has flagged Insmed Inc. as a potential merger candidate under the pro-business policies of the incoming Donald ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Analyst Joseph Schwartz of Leerink Partners reiterated a Buy rating on Insmed (INSM – Research Report), with a price target of $85.00.Stay ...

If you suddenly feel short of breath and a bit anxious, it might be something called "dyspnea." Let's dive into what the ...

Drug maker Insmed (INSM) is rising 6% today after it released on Friday afternoon its estimate of the revenue generated by ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Insmed (INSM – Research Report) today and set a price target of $75.00. The ...

Nicotine vaping cessation rates were elevated with use of a text message intervention or varenicline vs. no/minimal support or placebo, according to data published in Cochrane Database of ...

StockNews.com cut shares of Electromed (NYSE:ELMD – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. Electromed Price Performance Shares of NYSE ELMD opened at ...

以事件发生时间为序1、PCCM科规建-11种专病照护能力提升项目启动 2024年1月14日，PCCM科规建-11种专病照护能力提升项目在中国呼吸学科发展大会上正式启动。专病能力提升项目旨在让PCCM科规建已认定的单位在前期六个方面（科室建制、业务建制 ...

Ginger, echinacea, and curcumin are just a few of the herbs that you may hear about when looking into natural remedies for chronic obstructive pulmonary disease (COPD) or other respiratory conditions.